The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Evasion of the host phagocyte response by Staphylococcus aureus is crucial to successful infection with the pathogen. γ-haemolysin AB and CB (HlgAB, HlgCB) are bicomponent pore-forming toxins present in almost all human S. aureus isolates. Cellular tropism and contribution of the toxins to S. aureus pathophysiology are poorly understood. Here we identify the chemokine receptors CXCR1, CXCR2 and CCR2 as targets for HlgAB, and the complement receptors C5aR and C5L2 as targets for HlgCB. The receptor expression patterns allow the toxins to efficiently and differentially target phagocytic cells. Murine neutrophils are resistant to HlgAB and HlgCB. CCR2 is the sole murine receptor orthologue compatible with γ-haemolysin. In a murine peritonitis model, HlgAB contributes to S. aureus bacteremia in a CCR2-dependent manner. HlgAB-mediated targeting of CCR2(+) cells highlights the involvement of inflammatory macrophages during S. aureus infection. Functional quantification identifies HlgAB and HlgCB as major secreted staphylococcal leukocidins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The KD-value of HlgA for DARC is approximately 6-fold higher compared to CXCR1, which serves as a neutrophil receptor for HlgA (Spaan et al., 2014).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Spaan et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The affinity of the binding components HlgA and LukE for DARC is lower than their myeloid receptors, CXCR1 and CXCR2 (Reyes-Robles et al., 2013; Spaan et al., 2014).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Spaan et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Feil, E. J., Li, B. C., Aanensen, D. M., Hanage, W. P., & Spratt, B. G. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.5.1518-1530.2004 · Cited by 1,861
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,669
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
The Chemokine Superfamily Revisited
Zlotnik, A., & Yoshie, O. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.008 · Cited by 1,235
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Cited by
A guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Pore-forming toxins: ancient, but never really out of fashion
Peraro, M. D., & van der Goot, F. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.3 · Cited by 788
Staphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 598
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
“aureus survival and proliferation during bloodstream infection, likely through macrophage evasion and nutrient (Fe2+) release from erythrocytes [108,115].”
BackgroundStaphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0039-2018 · Cited by 452
Self-citationLeukocidins: staphylococcal bi-component pore-forming toxins find their receptors
Spaan, A. N., van Strijp, J. A. G., & Torres, V. J. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.27 · Cited by 347
Self-citationClinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023) · Antibiotics · doi:10.3390/antibiotics12030557 · Cited by 293
Staphylococcus aureus pathogenesis in diverse host environments
Balasubramanian, D., Harper, L., Shopsin, B., & Torres, V. J. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx005 · Cited by 240
Self-citationMiller, L. S., Fowler, V. G., Shukla, S. K., Rose, W. E., & Proctor, R. A. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz030 · Cited by 240
“PVL and HlgCB utilize C5aR1 and C5aR2 (Spaan et al. 2013a), LukED uses CCR5, CXCR1, and CXCR2 (Alonzo et al. 2013; Reyes-Robles et al. 2013), HlgAB and LukED share CXCR1 and CXCR2 as receptors but can also utilize CCR2 (Spaan et al. 2014), whereas LukAB binds to CD11b (DuMont et al. 2013).”
BackgroundFlannagan, R. S., Heit, B., & Heinrichs, D. E. (2016) · Cellular Microbiology · doi:10.1111/cmi.12527 · Cited by 217
“aureus produces toxins, such as LukAB, that specifically target and intoxicate phagocytes including macrophages (DuMont et al., 2013; Reyes-Robles et al., 2013; Spaan et al., 2014; Melehani et al., 2015).”
BackgroundResultInfluentialStaphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity
Seilie, E. S., & Bubeck Wardenburg, J. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.04.003 · Cited by 207
Bhattacharya, M., Berends, E. T. M., Chan, R., Schwab, E., Roy, S., Sen, C. K., Torres, V. J., & Wozniak, D. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721949115 · Cited by 198
“There are very few studies that clearly ascribe roles to γ-hemolysins HlgAB and HlgCB (37).”
BackgroundInfluentialSelf-citationAntimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus
Flannagan, R., Heit, B., & Heinrichs, D. (2015) · Pathogens · doi:10.3390/pathogens4040826 · Cited by 193
“with the exception that murine neutrophils are resistant to lysis [172]”
BackgroundMolecular Determinants in Phagocyte-Bacteria Interactions
Kaufmann, S. H. E., & Dorhoi, A. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.014 · Cited by 186
“PSMs promote neutrophil recruitment by binding to FPR1 and FPR2 (Thammavongsa et al., 2015) and induce lysis after phagocytosis of S. aureus (Surewaard et al., 2013).”
BackgroundBlake, K. J., Baral, P., Voisin, T., Lubkin, A., Pinho-Ribeiro, F. A., Adams, K. L., Roberson, D. P., Ma, Y. C., Otto, M., Woolf, C. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02448-6 · Cited by 184
Self-citationExploring the Role of Staphylococcus aureus in Inflammatory Diseases
Chen, H., Zhang, J., He, Y., Lv, Z., Liang, Z., Chen, J., Li, P., Liu, J., Yang, H., Tao, A., et al. (2022) · Toxins · doi:10.3390/toxins14070464 · Cited by 179
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity
Li, X. X., Lee, J. D., Kemper, C., & Woodruff, T. M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900371 · Cited by 148
“g-Hemolysin CB Staphylococcal toxin Human and rabbit C5aR1/C5aR2 Modulates receptor conformation; causes hetero-oligomerization and pore formation (67)”
BackgroundStaphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
“The affinity of the binding components HlgA and LukE for DARC is lower than their myeloid receptors, CXCR1 and CXCR2 (Reyes-Robles et al., 2013; Spaan et al., 2014).”
BackgroundSelf-citationBacterial Toxins as Pathogen Weapons Against Phagocytes
do Vale, A., Cabanes, D., & Sousa, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00042 · Cited by 138
“Gamma-hemolysin HlgAB andHlgCB bind chemokine receptors (e.g., CXCR1, CXCR2, and CCR2) and complement receptors (e.g., C5aR), respectively (Spaan et al., 2014), and promote the lysis of human neutrophils and macrophages in vitro.”
BackgroundMolecular Characteristics and Pathogenicity of Staphylococcus aureus Exotoxins
Zhu, Z., Zuo, H., Li, S., Fang, R., Ono, H. K., & Hu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010395 · Cited by 133
“Some studies suggest that HlgAB is necessary for the survival and proliferation of S. aureus during a blood infection, which is most likely caused by macrophage escape and nutrients (Fe 2+ ) released by red blood cells [149,151].”
BackgroundInfluentialHost-Pathogen Interactions in Gram-Positive Bacterial Pneumonia
Grousd, J. A., Rich, H. E. A., & Alcorn, J. F. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00107-18 · Cited by 107
“Panton-Valentine leukocidin (PVL), a bicomponent leukotoxin, recognizes the human complement 5a (C5a) receptors C5aR and C5L2, specifically targeting phagocytes (71, 73).”
BackgroundMarchetti, M., De Bei, O., Bettati, S., Campanini, B., Kovachka, S., Gianquinto, E., Spyrakis, F., & Ronda, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062145 · Cited by 97
Vrieling, M., Boerhout, E. M., van Wigcheren, G. F., Koymans, K. J., Mols-Vorstermans, T. G. T., de Haas, C. J. C., Aerts, P. C., Daemen, I., van Kessel, K. P. M., Koets, A. P., et al. (2016) · Scientific Reports · doi:10.1038/srep37759 · Cited by 103
Self-citationSpaan, A. N., Schiepers, A., de Haas, C. J. C., van Hooijdonk, D. D. J. J., Badiou, C., Contamin, H., Vandenesch, F., Lina, G., Gerard, N. P., Gerard, C. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500604 · Cited by 93
“Our data underscore previous observations that the mouse is a suboptimal mammalian species to investigate PVL and HlgCB in vivo (21, 24).”
BackgroundMethodResultInfluentialSelf-citationTromp, A. T., van Gent, M., Abrial, P., Martin, A., Jansen, J. P., de Haas, C. J. C., van Kessel, K. P. M., Bardoel, B. W., Kruse, E. M., Bourdonnay, E., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0159-x · Cited by 84
Self-citationVrieling, M., Koymans, K. J., Heesterbeek, D. A. C., Aerts, P. C., Rutten, V. P. M. G., de Haas, C. J. C., van Kessel, K. P. M., Koets, A. P., Nijland, R., & van Strijp, J. A. G. (2015) · mBio · doi:10.1128/mbio.00335-15 · Cited by 91
Self-citationThe Controversial C5a Receptor C5aR2: Its Role in Health and Disease
Zhang, T., Garstka, M. A., & Li, K. (2017) · Journal of Immunology Research · doi:10.1155/2017/8193932 · Cited by 72
“aureus isolates—γ-hemolysin CB (HIgCB) and one subunit of Panton-Valentine leukocidin- (PVL)- LukSPV—were found to target C5aRs with species specificity, which may provide insights into the binding characteristics of its ligands to C5aR2 [48, 128, 129].”
BackgroundAn Eye on Staphylococcus aureus Toxins: Roles in Ocular Damage and Inflammation
Astley, R., Miller, F. C., Mursalin, M. H., Coburn, P. S., & Callegan, M. C. (2019) · Toxins · doi:10.3390/toxins11060356 · Cited by 87
“HlgAB targets the chemokine receptors CXCR1, CXCR2, and CCR2 [105], while HlgCB targets the compliment component C5a receptors C5aR1 and C5aR2 [97].”
BackgroundInfluentialIdentification of LukPQ, a novel, equid-adapted leukocidin of Staphylococcus aureus
Koop, G., Vrieling, M., Storisteanu, D. M. L., Lok, L. S. C., Monie, T. P., van Wigcheren, G. F., Raisen, C. L., Ba, X., Gleadall, N., Hadjirin, N. F., et al. (2017) · Scientific Reports · doi:10.1038/srep40660 · Cited by 73
“Based on the high degree of similarity (91% amino-acid identity) between receptor binding components LukE and LukP, we hypothesized that the most likely receptors for LukPQ would comprise CXCR1, CXCR2, CCR5, and the Duffy antigen receptor (DARC) analogous to LukED 10,11 .”
InfluentialSelf-citationDiep, B. A., Le, V. T. M., Visram, Z., Rouha, H., Stulik, L., Dip, E. C., Nagy, G., & Nagy, E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01213-16 · Cited by 68
“The lack of sensitivity of murine neutrophils to LukSF-PV and the gamma-hemolysins arises from the lack of evolutionary conservation of their cognate receptors, which have been identified as the complement receptors C5aR and C5L2 for LukSF-PV and HlgCB and as the chemokine receptors CXCR1 and CXCR2 (and CCR2) for HlgA…”
BackgroundBalasubramanian, D., Ohneck, E. A., Chapman, J., Weiss, A., Kim, M. K., Reyes-Robles, T., Zhong, J., Shaw, L. N., Lun, D. S., Ueberheide, B., et al. (2016) · mBio · doi:10.1128/mbio.00818-16 · Cited by 68
Self-citationTseng, C. W., Biancotti, J. C., Berg, B. L., Gate, D., Kolar, S. L., Müller, S., Rodriguez, M. D., Rezai-Zadeh, K., Fan, X., Beenhouwer, D. O., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005292 · Cited by 67
“Two particular factors, HlgBC and CHIPS, selectively bind human C5aR [3,30,31].”
BackgroundInnate Immune Signaling Activated by MDR Bacteria in the Airway
Parker, D., Ahn, D. S., Cohen, T. S., & Prince, A. S. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2015 · Cited by 75
Exploiting dominant‐negative toxins to combat Staphylococcus aureus pathogenesis
Robles, T. R., Lubkin, A., Alonzo, F., Lacy, D. B., & Torres, V. J. (2016) · EMBO Reports · doi:10.15252/embr.201540994 · Cited by 63
“However, the identification of different proteinaceous cellular receptors targeted by these toxins on the surface of leukocytes challenges the notion of redundancy and provides an explanation for their cell and species tropism [10 – 14].”
InfluentialSelf-citationHumanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia
Prince, A., Wang, H., Kitur, K., & Parker, D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw425 · Cited by 60
Staphylococcal Immune Evasion Proteins: Structure, Function, and Host Adaptation
Koymans, K. J., Vrieling, M., Gorham, R. D., & van Strijp, J. A. G. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5017 · Cited by 66
Self-citationStaphylococcus aureus Arsenal To Conquer the Lower Respiratory Tract
Pivard, M., Moreau, K., & Vandenesch, F. (2021) · mSphere · doi:10.1128/msphere.00059-21 · Cited by 69
“In addition to inflammasome activation in immune cells, most of these toxins, such as PVL and gamma-hemolysin, can lyse macrophages and neutrophils (119, 122), leading to an involuntary release of cytokines and exacerbating local inflammation.”
BackgroundSelf-citationShumba, P., Shambat, S. M., & Siemens, N. (2019) · Toxins · doi:10.3390/toxins11060332 · Cited by 62
“In contrast, HlgCB interacts with human neutrophils and monocytes via complement receptors C5aR1 and C5aR2 [131].”
BackgroundInfluentialStaphylococcus aureus , Antibiotic Resistance, and the Interaction with Human Neutrophils
Rungelrath, V., & DeLeo, F. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8127 · Cited by 68
“Leukocidin GH/AB (LukGH/LukAB) CD11b PMN lysis (41, 182) c-Hemolysin AB, BC (HlgAB, HlgBC) C-X-C motif chemokine receptor (CXCR1, CXCR2, CXCR4), C-C motif chemokine receptor 2 (CCR2) PMN lysis (164)”
BackgroundMacrophage cell death in microbial infections
Chow, S. H., Deo, P., & Naderer, T. (2016) · Cellular Microbiology · doi:10.1111/cmi.12573 · Cited by 59
“aureus infections remain largely elusive but they may induce similar necrotizing pneumonia (Spaan et al., 2014).”
BackgroundMechanisms of host adaptation by bacterial pathogens
Barber, M. F., & Fitzgerald, J. R. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae019 · Cited by 72
“While the S. aureus Panton–Valentine leucocidin (PVL) and HlgCB have both previously been shown to specificall y tar get human C5aR1 (Spaan et al. 2013 , 2014 ), a more r ecent study demonstr ated that mice expr essing C5aR1 ar e susceptible to HlgCB but not PVL (Tromp et al. 2018 ).”
BackgroundHost factors that contribute to recurrent staphylococcal skin infection
Montgomery, C. P., David, M. Z., & Daum, R. S. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000156 · Cited by 57
Badarau, A., Rouha, H., Malafa, S., Battles, M. B., Walker, L., Nielson, N., Dolezilkova, I., Teubenbacher, A., Banerjee, S., Maierhofer, B., et al. (2016) · mAbs · doi:10.1080/19420862.2016.1215791 · Cited by 48
Rouha, H., Weber, S., Janesch, P., Maierhofer, B., Gross, K., Doležílková, I., Mirkina, I. I., Visram, Z., Malafa, S., Stulik, L., et al. (2017) · Virulence · doi:10.1080/21505594.2017.1391447 · Cited by 48
Studying Staphylococcal Leukocidins: A Challenging Endeavor
Tromp, A. T., & van Strijp, J. A. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00611 · Cited by 51
“The lack of an adequate in vivo model additionally hinders the assessment of the apparent redundant deployment of two leukocidins that target the same human C5aR1 (Spaan et al., 2013a, 2014, 2015b).”
BackgroundInfluentialCounter inhibition between leukotoxins attenuates Staphylococcus aureus virulence
Yoong, P., & Torres, V. J. (2015) · Nature Communications · doi:10.1038/ncomms9125 · Cited by 41
Self-citationStaphylococcus aureus Leukocidins Target Endothelial DARC to Cause Lethality in Mice
Lubkin, A., Lee, W. L., Alonzo, F., Wang, C., Aligo, J. A., Keller, M., Girgis, N. M., Robles, T. R., Chan, R., O’Malley, A., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.015 · Cited by 41
“Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.”
BackgroundInfluentialSelf-citationMelehani, J. H., & Duncan, J. A. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_13 · Cited by 43
“…Hla and A Disintegrin And Metalloprotease 10 (ADAM10) (Wilke and Bubeck Wardenburg 2010); HlgAB and CXCR1, CXCR2 and CCR2; HlgCB and C5aR and C5L2 (Spaan et al. 2014); LukAB and CD11b (DuMont et al. 2013a), LukED and CCR5 (Alonzo et al. 2013), CXCR1 and CXCR2 (Reyes-Robles et al. 2013); and PVL…”
InfluentialRidder, M. J., Daly, S. M., Hall, P. R., & Bose, J. L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1550-8_4 · Cited by 40
He, C., Xu, S., Zhao, H., Hu, F., Xu, X., Jin, S., Han, Y., Gong, F., & Liu, Q. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3297-0 · Cited by 44
Epidemiological and Clinical Evidence for the Role of Toxins in S. aureus Human Disease
Bennett, M. R., & Thomsen, I. P. (2020) · Toxins · doi:10.3390/toxins12060408 · Cited by 40
Staphylococcus aureus Pore-Forming Toxins
Robles, T. R., & Torres, V. J. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_16 · Cited by 41
Self-citationMetabolism Shapes Immune Responses to Staphylococcus aureus
Arumugam, P., & Kielian, T. (2024) · Journal of Innate Immunity · doi:10.1159/000535482 · Cited by 35
Adhikari, R. P., Kort, T., Shulenin, S., Kanipakala, T., Ganjbaksh, N., Roghmann, M., Holtsberg, F. W., & Aman, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137874 · Cited by 38
“Spaan et al [42] identified three specific receptors, CXCR1, CXCR2, and CCR2 for HlgAB, and two receptors, C5aR and C5L2 for HlgCB.”
BackgroundInfluentialStaphylococcus aureus: setting its sights on the human innate immune system
Buchan, K. D., Foster, S. J., & Renshaw, S. A. (2019) · Microbiology · doi:10.1099/mic.0.000759 · Cited by 43
Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia
Tam, K., Lacey, K. A., Devlin, J. C., Coffre, M., Sommerfield, A. G., Chan, R., O’Malley, A., Koralov, S. B., Loke, P., & Torres, V. J. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190541 · Cited by 33
Self-citationDynamic interactions between dermal macrophages and Staphylococcus aureus
Feuerstein, R., Kolter, J., & Henneke, P. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-097rr · Cited by 34
“thereby selectively targeting and lysing phagocytes at the site of infection [23].”
BackgroundSultan, A. R., Swierstra, J., Toom, N. A. L.-D., Snijders, S. V., Maňásková, S. H., Verbon, A., & van Wamel, W. J. B. (2018) · Infection and Immunity · doi:10.1128/iai.00352-18 · Cited by 38
Functional classification of protein toxins as a basis for bioinformatic screening
Negi, S. S., Schein, C. H., Ladics, G. S., Mirsky, H. P., Chang, P. L., Rascle, J.-B., Kough, J. L., Sterck, L., Papineni, S., Jez, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13957-1 · Cited by 32
Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus
Chan, R., Buckley, P. T., O’Malley, A., Sause, W. E., Alonzo, F., Lubkin, A., Boguslawski, K. M., Payne, A., Fernandez, J., Strohl, W. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0882 · Cited by 31
Self-citationThomas, A., Chothe, S. K., Byukusenge, M., Mathews, T., Pierre, T., Kariyawasam, S., Luley, E., Kuchipudi, S. V., & Jayarao, B. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248528 · Cited by 31
“LukED has the ability to permeabilize and kill cells such as neutrophils carrying the corresponding receptors [80].”
BackgroundGrażul, M., Balcerczak, E., & Sienkiewicz, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20065155 · Cited by 29
“, bacteremia and septic arthritis [3], and pathogenic processes of toxic shock syndrome (TSS) as it affects polymorph nuclear cells, monocytes, macrophages, and erythrocytes.”
BackgroundThomsen, I. P., & Liu, G. Y. (2018) · JCI Insight · doi:10.1172/jci.insight.98216 · Cited by 30
“In addition, toxin monomers appear to antagonize their receptors, which may interfere with phagocyte recruitment and function (61, 62).”
BackgroundWolfmeier, H., Mansour, S., Liu, L. T., Pletzer, D., Draeger, A., Babiychuk, E. B., & Hancock, R. E. W. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.06.016 · Cited by 29
Luo, Y., Jia, X., Wu, X., Diao, L., Zhao, Y., Liu, X., Peng, Y., Zhong, W., Xing, M. M. Q., & Lyu, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03056-5 · Cited by 28
Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56bright NK Cells
Guan, Z., Liu, Y., Liu, C., Wang, H., Feng, J., & Yang, G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.658141 · Cited by 26
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies
Hsieh, R. C., Liu, R., Burgin, D. J., & Otto, M. J. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2242585 · Cited by 26
Genetic variation of staphylococcal LukAB toxin determines receptor tropism
Perelman, S. S., James, D. B. A., Boguslawski, K. M., Nelson, C. W., Ilmain, J. K., Zwack, E. E., Prescott, R. A., Mohamed, A., Tam, K., Chan, R., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00890-3 · Cited by 24
Self-citationSi, Y., Zhao, F., Beesetty, P., Weiskopf, D., Li, Z., Tian, Q., Alegre, M., Sette, A., Chong, A. S., & Montgomery, C. P. (2020) · Science Advances · doi:10.1126/sciadv.aaw7713 · Cited by 24
Flammier, S., Rasigade, J., Badiou, C., Henry, T., Vandenesch, F., Laurent, F. J., & Trouillet‐Assant, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150693 · Cited by 23
“Noteworthy, several of the aforementioned toxins exhibit some degree of specificity with respect to immune cells through the specific binding of cell surface receptors [10].”
BackgroundSelf-citationBadarau, A., Trstenjak, N., & Nagy, E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_200 · Cited by 20
Molecular insights into mechanisms of GPCR hijacking by Staphylococcus aureus
Grison, C. M., Lambey, P., Jeannot, S., Nero, E. D., Fontanel, S., Peysson, F., Heuninck, J., Sounier, R., Durroux, T., Leyrat, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2108856118 · Cited by 25
Tam, K., Schultz, M. L., Robles, T. R., Vanwalscappel, B., Horton, J. D., Alonzo, F., Wu, B., Landau, N. R., & Torres, V. J. (2016) · mBio · doi:10.1128/mbio.02024-16 · Cited by 22
Self-citationHu, H., Liu, M., & Sun, S. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s322393 · Cited by 19
“This oligomerization process may occur before the PFT inserts into the cell membrane, or during interaction of the monomers with membrane receptors.(12) It has become necessary to continuously develop new treatments to cope with the toxin-producing pathogens.”
BackgroundInfluentialMessing with the Sentinels—The Interaction of Staphylococcus aureus with Dendritic Cells
Darisipudi, M. N., Nordengrün, M., Bröker, B. M., & Péton, V. (2018) · Microorganisms · doi:10.3390/microorganisms6030087 · Cited by 25
Staphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch40 · Cited by 39
Self-citationComplex Regulation of Gamma-Hemolysin Expression Impacts Staphylococcus aureus Virulence
Pivard, M., Caldelari, I., Brun, V., Croisier, D., Jaquinod, M., Anzala, N., Gilquin, B., Teixeira, C., Benito, Y., Couzon, F., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01073-23 · Cited by 21
Self-citationTawk, M. Y., Zimmermann, K., Bossu, J. L., Potrich, C., Bourcier, T., Serra, M. D., Poulain, B., Prévost, G., & Jover, E. (2015) · Cellular Microbiology · doi:10.1111/cmi.12434 · Cited by 20
“PVL and HlgC/HlgB bind to the C5aR and mobilize intracellular Ca2+ Previous work from our group showed that S-subunits of the PVL and the γ-haemolysin HlgC/HlgB compete for the same binding site (Gauduchon et al., 2001), now identified as the C5a peptide receptor C5aR (Spaan et al., 2013; 2014).”
BackgroundResultStrategies for Survival of Staphylococcus aureus in Host Cells
Xu, H., Wang, S., Liu, X., Li, M., Wang, X., Chen, H., Qu, C., Liu, Y., & Liu, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020720 · Cited by 16
“Following the knockout of the HlgAB toxin, there was a reduction in the bacterial load present within the cells [23].”
Janesch, P., Rouha, H., Weber, S., Malafa, S., Gross, K., Maierhofer, B., Badarau, A., Visram, Z., Stulik, L., & Nagy, E. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.02.004 · Cited by 16
“155 We determined the cytotoxic potencies of the five S. aureus leukocidins - LukSF-PV, LukGH, 156 HlgAB, HlgCB and LukED- towards freshly isolated human PMNs over a broad concentration 157 range by measuring cellular ATP levels.”
BackgroundInfluentialHost–Receptor Post-Translational Modifications Refine Staphylococcal Leukocidin Cytotoxicity
Tromp, A. T., van Gent, M., Jansen, J. P., Scheepmaker, L. M., Velthuizen, A., de Haas, C. J. C., van Kessel, K. P. M., Bardoel, B. W., Boettcher, M., McManus, M. T., et al. (2020) · Toxins · doi:10.3390/toxins12020106 · Cited by 15
“HlgAB targets CXCR1, CXCR2 and CC‐chemokine receptor 2 (CCR2) [8].”
BackgroundMethodResultSelf-citationArya, R., Kim, T., Youn, J. W., Bae, T., & Kim, K. K. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268044 · Cited by 13
Wang, Y., Dikeman, D. A., Zhang, J., Ackerman, N. E., Kim, S., Alphonse, M. P., Ortines, R. V., Liu, H., Joyce, D. P., Dillen, C. A., et al. (2021) · Journal of Orthopaedic Research® · doi:10.1002/jor.25027 · Cited by 17
“aureus virulence.(27,28) Therefore, in this study, we set out to de-”
BackgroundHorst, S. A., Itzek, A., Klos, A., Beineke, A., & Medina, E. (2015) · Pathogens · doi:10.3390/pathogens4040722 · Cited by 15
Ledo, C., Gonzalez, C. D., Garófalo, A. N., Sabbione, F., Keitelman, I. A., Giai, C., Stella, I., Trevani, A. S., & Gómez, M. I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.524180 · Cited by 15
“aureus has the particular characteristic of harboring surface molecules that bind to or signal through host molecules other than conventional PRRs, as it is the case of pore forming toxins such as a-toxin that binds ADAM 10 (39), HlgAB that binds CCR2 and CXCR1/2 (40), HlgCB that binds C5aR (40), Luk ED that binds CCR…”
BackgroundApostolakos, I., Skarlatoudi, T., Vatavali, K. A., Giannouli, A., Bosnea, L. A., & Mataragas, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813883 · Cited by 14
“Gamma- and alpha-hemolysins are associated with cytotoxicity and hemolytic activity and their presence in staphylococcal strains further highlighted their virulence potential and pathogenicity [41,42].”
BackgroundHung, C.-H., Chan, K. H., Kong, W.-P., Du, R.-L., Ding, K., Liang, Z., Wang, Y., & Wong, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00403 · Cited by 13
Fulminant Staphylococcal Infections
Gillet, Y., Henry, T., & Vandenesch, F. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0036-2018 · Cited by 16
Self-citationMishra, S., Roy, A., & Dutta, S. (2023) · Structure · doi:10.1016/j.str.2023.03.009 · Cited by 15
Structural insights into recognition of chemokine receptors by Staphylococcus aureus leukotoxins
Lambey, P., Otun, O., Cong, X., Hoh, F., Brunel, L., Verdié, P., Grison, C. M., Peysson, F., Jeannot, S., Durroux, T., et al. (2022) · eLife · doi:10.7554/elife.72555 · Cited by 14
Leseigneur, C., Boucontet, L., Duchateau, M., Pizarro‐Cerdá, J., Matondo, M., Colucci‐Guyon, E., & Dussurget, O. (2022) · eLife · doi:10.7554/elife.79941 · Cited by 13
Pivard, M., Bastien, S., Macavei, I., Mouton, N., Rasigade, J., Couzon, F., Youenou, B., Tristan, A., Carrière, R., Moreau, K., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1162617 · Cited by 12
Self-citationPeng, Z., Takeshita, M., Shibata, N., Tada, H., Tanaka, Y., & Kaneko, J. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy030 · Cited by 9
Hernandez, D. N., Tam, K., Shopsin, B., Radke, E. E., Law, K., Cardozo, T. J., Torres, V. J., & Silverman, G. J. (2020) · mBio · doi:10.1128/mbio.00460-20 · Cited by 11
Self-citationHodille, E., Pleșa, A., Bourrelly, E., Belmont, L., Badiou, C., Lina, G., & Dumitrescu, O. (2020) · Toxins · doi:10.3390/toxins12110725 · Cited by 11
“We have shown that staphylococcal Hlgs (HlgAB and HlgCB in the same assay) was able to lyse bone marrow leucocytes, in particular CD11b+ monocytes, which expressed the four tested receptors (C5aR, CXCR1, CXCR2, and CCR2), but not PMN or Gr2, which expressed only CXCR1 and C5aR.”
BackgroundSelf-citationGillman, A. N., Breshears, L. M., Kistler, C. A., Finnegan, P., Torres, V. J., Schlievert, P. M., & Peterson, M. L. (2017) · Toxins · doi:10.3390/toxins9070202 · Cited by 9
“The abundance of CXCR1 versus C5aR may partially explain the differences in binding b-HlgA (93”
BackgroundMethodSelf-citationExotoxins of Staphylococcus aureus
Hu, D., Ono, H. K., Li, S., & Fang, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-9428-1_3 · Cited by 12
Bertrand, B. P., Shinde, D. D., Thomas, V. C., Whiteley, M., Ibberson, C. B., & Kielian, T. (2024) · Infection and Immunity · doi:10.1128/iai.00474-23 · Cited by 11
“Species specificity has also been observed for these toxins where HlgAB, HlgCB, PVL, and LukAB, are highly cytolytic for human leukocytes compared to murine cells (10, 13, 14).”
BackgroundMembrane binding of pore-forming γ-hemolysin components studied at different lipid compositions
Tarenzi, T., Lattanzi, G., & Potestio, R. (2022) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2022.183970 · Cited by 9
Hung, S., Dreher, L., Diessner, J., Schwarz, Š., Ohlsen, K., & Hertlein, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892053 · Cited by 7
“aureus show higher affinity or activity towards human than murine immune cells in vitro, like bi-component toxins, superantigens or immunomodulators (6, 29, 34), it seems reasonable to assume, that humanized mice are indeed representing the clinical course of infection more closely than wild-type mice.”
Background
Metadata
- Authors
- Spaan, A. N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E. A., Benito, Y., de Haas, C. J. C., Day, C. J., Jennings, M. P., Lina, G., Vandenesch, F., van Kessel, K. P. M., Torres, V. J., van Strijp, J. A. G., & Henry, T.
- Affiliations
- Lyon 1 Université (FR)
- University Medical Center Utrecht (NL)
- New York University (US)
- Griffith University (AU)
- ORCID
- Venue
- Nature Communications
- Published
- 2014-11-11
- Volume
- 5
- Issue
- 1
- Pages
- 5438-5438
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4228697
- OpenAlex
- W2084502463
- Cited by
- 166
- References
- 63
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 11 · 2023: 16 · 2022: 10 · 2021: 13 · 2020: 17 · 2019: 13 · 2018: 17 · 2017: 14 · 2016: 15 · 2015: 17
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Griffith Research Online (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Fondation Innovations en Infectiologie
- Agence Nationale de la Recherche
- National Institutes of Health (HHSN272200700055C)
- National Health and Medical Research Council (565526)
- National Institute of Allergy and Infectious Diseases (AI105129, HHSN272200700055C, F31AI112290, T32AI007180, R01AI105129, AI007180)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- Staphylococcus aureus, pore-forming toxins, leukocidin, CCR2, CXCR1, CXCR2, neutrophils, inflammatory macrophages, bacteremia, peritonitis, host immune evasion, receptor specificity
- MeSH terms
- Animals, Bacterial Proteins, Bacterial Toxins, Cells, Cultured, Disease Models, Animal, Female, Hemolysin Proteins, Humans, Macrophages, Male, Mice, Inbred C57BL, Peritonitis, Phagocytes, Receptors, Complement, Staphylococcal Infections, Staphylococcus aureus, Mice, Knockout, Receptors, Chemokine, Receptors, Interleukin-8A, Receptors, Interleukin-8B, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.